<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2-antibiotics-09-00406">
 <label>2.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gilbert</surname>
    <given-names>D.N.</given-names>
   </name>
   <name>
    <surname>Guidos</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Boucher</surname>
    <given-names>H.W.</given-names>
   </name>
   <name>
    <surname>Talbot</surname>
    <given-names>G.H.</given-names>
   </name>
   <name>
    <surname>Spellberg</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Edwards</surname>
    <given-names>J.E.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Scheld</surname>
    <given-names>W.M.</given-names>
   </name>
   <name>
    <surname>Bradley</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>John</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Bartlett</surname>
    <given-names>J.G.</given-names>
   </name>
  </person-group>
  <article-title>The 10 x â€™20 Initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020</article-title>
  <source>Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.</source>
  <year>2010</year>
  <volume>50</volume>
  <fpage>1081</fpage>
  <lpage>1083</lpage>
  <pub-id pub-id-type="doi">10.1086/652237</pub-id>
 </element-citation>
</ref>
